Hakutulokset - Shomron Ben–Horin

Tarkenna hakua
  1. 1
    Review article: loss of response to anti-TNF treatments in Crohn’s disease

    Review article: loss of response to anti-TNF treatments in Crohn’s disease Tekijä Shomron Ben–Horin, Yehuda Chowers

    Julkaistu 2011
    Hae kokoteksti Hae kokoteksti
    Revisão
    Lisää suosikkeihin
    Tallennettuna:
  2. 2
    Therapeutic Drug Monitoring in Inflammatory Bowel Disease

    Therapeutic Drug Monitoring in Inflammatory Bowel Disease Tekijä Uri Kopylov, Shomron Ben–Horin, Ernest G. Seidman

    Julkaistu 2017
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  3. 3
    Large Symptomatic Pericardial Effusion as the Presentation of Unrecognized Cancer

    Large Symptomatic Pericardial Effusion as the Presentation of Unrecognized Cancer Tekijä Shomron Ben–Horin, Ilan Bank, Victor Guetta, Avi Livneh

    Julkaistu 2006
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  4. 4
    A Gastroenterologist's guide to drug interactions of small molecules for inflammatory bowel disease

    A Gastroenterologist's guide to drug interactions of small molecules for inflammatory bowel disease Tekijä Sivan Harnik, Bella Ungar, Ronen Loebstein, Shomron Ben‐Horin

    Julkaistu 2024
    Hae kokoteksti Hae kokoteksti
    Revisão
    Lisää suosikkeihin
    Tallennettuna:
  5. 5
    Magnetic resonance enterography in Crohn's disease: A guide to common imaging manifestations for the IBD physician

    Magnetic resonance enterography in Crohn's disease: A guide to common imaging manifestations for the IBD physician Tekijä Marianne Michal Amitai, Shomron Ben–Horin, Rami Eliakim, Uri Kopylov

    Julkaistu 2012
    Hae kokoteksti
    Revisão
    Lisää suosikkeihin
    Tallennettuna:
  6. 6
    Oral Crohn's disease: Is it a separable disease from orofacial granulomatosis? A review

    Oral Crohn's disease: Is it a separable disease from orofacial granulomatosis? A review Tekijä Andrew P. Zbar, Shomron Ben–Horin, Marc Beer-Gabel, Rami Eliakim

    Julkaistu 2011
    Hae kokoteksti Hae kokoteksti
    Revisão
    Lisää suosikkeihin
    Tallennettuna:
  7. 7
    Biosimilars in Inflammatory Bowel Disease: Facts and Fears of Extrapolation

    Biosimilars in Inflammatory Bowel Disease: Facts and Fears of Extrapolation Tekijä Shomron Ben–Horin, Niels Vande Casteele, Stefan Schreiber, Péter L. Lakatos

    Julkaistu 2016
    Hae kokoteksti Hae kokoteksti
    Revisão
    Lisää suosikkeihin
    Tallennettuna:
  8. 8
    Anti-tumor necrosis factor and postoperative complications in Crohnʼs disease: systematic review and meta-analysis

    Anti-tumor necrosis factor and postoperative complications in Crohnʼs disease: systematic review and meta-analysis Tekijä Uri Kopylov, Shomron Ben–Horin, Oded Zmora, Rami Eliakim, Lior H. Katz

    Julkaistu 2012
    Hae kokoteksti Hae kokoteksti
    Revisão
    Lisää suosikkeihin
    Tallennettuna:
  9. 9
    The immunogenicity of biosimilar infliximab: can we extrapolate the data across indications?

    The immunogenicity of biosimilar infliximab: can we extrapolate the data across indications? Tekijä Shomron Ben–Horin, Graham Heap, Tariq Ahmad, HoUng Kim, T. Kwon, Yehuda Chowers

    Julkaistu 2015
    Hae kokoteksti Hae kokoteksti
    Revisão
    Lisää suosikkeihin
    Tallennettuna:
  10. 10
    TNF-Alpha Blockers in Inflammatory Bowel Diseases: Practical Recommendations and a User’s Guide: An Update

    TNF-Alpha Blockers in Inflammatory Bowel Diseases: Practical Recommendations and a User’s Guide: An Update Tekijä Marianne Vullièmoz, Stephan Brand, Pascal Juillerat, Christian Mottet, Shomron Ben–Horin, Pierre Michetti

    Julkaistu 2020
    Hae kokoteksti Hae kokoteksti
    Revisão
    Lisää suosikkeihin
    Tallennettuna:
  11. 11
    Vedolizumab in IBD–Lessons From Real-world Experience; A Systematic Review and Pooled Analysis

    Vedolizumab in IBD–Lessons From Real-world Experience; A Systematic Review and Pooled Analysis Tekijä Tal Engel, Bella Ungar, Diana E. Yung, Shomron Ben–Horin, Rami Eliakim, Uri Kopylov

    Julkaistu 2017
    Hae kokoteksti
    Revisão
    Lisää suosikkeihin
    Tallennettuna:
  12. 12
    Antiviral therapy in cytomegalovirus-positive ulcerative colitis: A systematic review and meta-analysis

    Antiviral therapy in cytomegalovirus-positive ulcerative colitis: A systematic review and meta-analysis Tekijä Uri Kopylov, Noa Eliakim‐Raz, Andrew Szilagy, Ernest G. Seidman, Shomron Ben‐Horin, Lior H. Katz

    Julkaistu 2014
    Hae kokoteksti
    Revisão
    Lisää suosikkeihin
    Tallennettuna:
  13. 13
    The Lewis score or the capsule endoscopy Crohn’s disease activity index: which one is better for the assessment of small bowel inflammation in established Crohn’s disease?

    The Lewis score or the capsule endoscopy Crohn’s disease activity index: which one is better for the assessment of small bowel inflammation in established Crohn’s disease? Tekijä Doron Yablecovitch, Adi Lahat, Sandra Neuman, Nina Levhar, Benjamin Avidan, Shomron Ben–Horin, Rami Eliakim, Uri Kopylov

    Julkaistu 2018
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  14. 14
    Capsule Endoscopy, Magnetic Resonance Enterography, and Small Bowel Ultrasound for Evaluation of Postoperative Recurrence in Crohn’s Disease: Systematic Review and Meta-Analysis

    Capsule Endoscopy, Magnetic Resonance Enterography, and Small Bowel Ultrasound for Evaluation of Postoperative Recurrence in Crohn’s Disease: Systematic Review and Meta-Analysis Tekijä Diana E. Yung, Ofir Har‐Noy, Yuen Sau Tham, Shomron Ben–Horin, Rami Eliakim, Anastasios Koulaouzidis, Uri Kopylov

    Julkaistu 2017
    Hae kokoteksti Hae kokoteksti
    Revisão
    Lisää suosikkeihin
    Tallennettuna:
  15. 15
    Effects of Combination Therapy With Immunomodulators on Trough Levels and Antibodies Against Tumor Necrosis Factor Antagonists in Patients With Inflammatory Bowel Disease: A Meta-analysis

    Effects of Combination Therapy With Immunomodulators on Trough Levels and Antibodies Against Tumor Necrosis Factor Antagonists in Patients With Inflammatory Bowel Disease: A Meta-a... Tekijä Yun Qiu, Ren Mao, Baili Chen, Shenghong Zhang, Jing Guo, Yao He, Zhirong Zeng, Shomron Ben–Horin, Minhu Chen

    Julkaistu 2017
    Hae kokoteksti Hae kokoteksti
    Revisão
    Lisää suosikkeihin
    Tallennettuna:
  16. 16
    Fecal calprotectin for detection of postoperative endoscopic recurrence in Crohn’s disease: systematic review and meta-analysis

    Fecal calprotectin for detection of postoperative endoscopic recurrence in Crohn’s disease: systematic review and meta-analysis Tekijä Yuen Sau Tham, Diana E. Yung, Shmuel Fay, Takayuki Yamamoto, Shomron Ben–Horin, Rami Eliakim, Anastasios Koulaouzidis, Uri Kopylov

    Julkaistu 2018
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  17. 17
    Differences in disease characteristics and treatment exposures between paediatric and adult‐onset inflammatory bowel disease using a registry‐based cohort

    Differences in disease characteristics and treatment exposures between paediatric and adult‐onset inflammatory bowel disease using a registry‐based cohort Tekijä Maya Granot, Uri Kopylov, Nurit Loberman‐Nachum, Alexander Krauthammer, C M Abitbol, Shomron Ben–Horin, Batia Weiss, Yael Haberman

    Julkaistu 2024
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  18. 18
    A novel PillCam Crohn’s capsule score (Eliakim score) for quantification of mucosal inflammation in Crohn’s disease

    A novel PillCam Crohn’s capsule score (Eliakim score) for quantification of mucosal inflammation in Crohn’s disease Tekijä Rami Eliakim, Doron Yablecovitch, Adi Lahat, Bella Ungar, Eyal Shachar, Dan Carter, Limor Selinger, Sandra Neuman, Shomron Ben–Horin, Uri Kopylov

    Julkaistu 2020
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  19. 19
    Undetectable anti‐<scp>TNF</scp> drug levels in patients with long‐term remission predict successful drug withdrawal

    Undetectable anti‐<scp>TNF</scp> drug levels in patients with long‐term remission predict successful drug withdrawal Tekijä Shomron Ben–Horin, Yehuda Chowers, Bella Ungar, Uri Kopylov, Ronen Loebstein, B. Weiß, Rami Eliakim, Émilie Del Tedesco, Stéphane Paul, Xavier Roblin

    Julkaistu 2015
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  20. 20
    Clinical utility of antihuman lambda chain-based enzyme-linked immunosorbent assay (ELISA) versus double antigen ELISA for the detection of anti-infliximab antibodies

    Clinical utility of antihuman lambda chain-based enzyme-linked immunosorbent assay (ELISA) versus double antigen ELISA for the detection of anti-infliximab antibodies Tekijä Uri Kopylov, Yoav Mazor, Miri Yavzori, Ella Fudim, Lior H. Katz, D. Coscas, Orit Picard, Yehuda Chowers, Rami Eliakim, Shomron Ben–Horin

    Julkaistu 2011
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:

Työkalut: